To the Editor-Surgical site infection (SSI) among patients undergoing oncosurgery for cancer can increase the chances of morbidity and mortality, delay discharge from the hospital, increase healthcare costs, and affect subsequent management of cancers (through the delay of chemotherapy or radiotherapy). 1 The challenges of SSI are greater in low-and middle-income countries because of resource constraints and due to endemicity of multidrug-resistant gram-negative bacteria (MDR-GNB), which colonizes and infects patients in significant numbers. 2-4 SSI rates are also influenced by preoperative comorbidities. [5][6][7] In the current study, we report the impact of significant MDR-GNB colonization and concurrent comorbidity on SSI and long-term surgical outcomes.The current retrospective study was conducted among patients operated for endometrial cancer in an oncology center in eastern India between 2011 and 2016. In total, 150 patients underwent gynecological oncosurgery during this period. Most patients in the study population were of postmenopausal age (median age, 58 years; range, 34-81 years; interquartile range [IQR], 54-64 years). Most patients were overweight or obese (median body mass index, 30 kg/ m 2 ; IQR, 26-33 kg/m 2 ; range, 14-48 kg/m 2 ). Of the 150 patients, 113 (75%) had 1 or more comorbidities (eg, asthma, diabetes, hypertension, hypothyroidism). Hypertension was the most common comorbidity, affecting 86 of 150 patients, followed by diabetes mellitus in 61 of 150 patients (40.6%) and hypothyroidism in 42 of 150